VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AFJK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AFJKAimei Health Technology Co., Ltd
$27.54$169M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAFJKQuarterly Financials

Aimei Health Technology Co., Ltd (AFJK) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Aimei Health Technology Co., Ltd (AFJK) quarterly income statement — complete revenue, gross profit & net income history

AFJK Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Net Interest Income107.42K348.71K482.17K466.57K598.08K846.13K943.53K918.21K909.13K199.85K
NII Growth %-82.04%-58.79%-48.9%-49.19%-34.21%323.39%----
Net Interest Margin %0.87%2.88%1.06%1.05%1.37%1.15%1.3%1.28%1.28%0.28%
Interest Income107.42K348.71K482.17K466.57K598.08K846.13K943.53K918.21K909.13K199.85K
Interest Expense0000000000
Loan Loss Provision0000000000
Non-Interest Income-107.42K-348.71K-482.17K-466.57K-598.08K-846.13K-943.53K-918.21K-909.13K-199.85K
Non-Interest Income %----------
Total Revenue0000000000
Revenue Growth %----------
Non-Interest Expense61.98K250.59K130.15K41.6K413.41K402.02K200.02K309.11K153.63K24.84K
Efficiency Ratio----------
Operating Income-61.98K-250.59K-130.15K-41.6K-413.41K-402.02K-200.02K-309.11K-153.63K-24.84K
Operating Margin %----------
Operating Income Growth %85.01%37.67%34.93%86.54%-169.09%-1518.38%----
Pretax Income45.44K98.12K352.02K424.97K184.66K444.11K743.51K609.09K755.5K175.01K
Pretax Margin %----------
Income Tax0000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%
Net Income45.44K98.12K352.02K424.97K184.66K444.11K743.51K609.09K755.5K175.01K
Net Margin %----------
Net Income Growth %-75.39%-77.91%-52.65%-30.23%-75.56%153.77%----
Net Income (Continuing)45.44K98.12K352.02K424.97K184.66K444.11K743.51K609.09K755.5K175.01K
EPS (Diluted)0.010.020.060.070.020.050.080.070.080.02
EPS Growth %-29.76%-51.63%-27.18%2.81%-75.51%153.61%----
EPS (Basic)0.010.020.060.070.020.050.080.070.080.02
Diluted Shares Outstanding1.04M4.05M4M6.12M9.03M9.03M9.03M9.03M9.03M9.03M